Successful endoscopic management of post-coloplasty cervical esophagocutaneous fistula using sequential diabolo and fully covered stents. [PDF]
Sais A +6 more
europepmc +1 more source
ABSTRACT Background Although semaglutide 2.4 mg has demonstrated significant weight loss efficacy in clinical trials, real‐world data, particularly with regard to clinically complex and underrepresented populations, remain limited. Objectives The study aims to assess the real‐world effectiveness and patient‐reported outcomes associated with the use of ...
Pierre Bel Lassen +20 more
wiley +1 more source
Short‐ and long‐term outcome of neonates with thrombocytopenia from maternal immune thrombocytopenia
British Journal of Haematology, EarlyView.
Boris Sorin +21 more
wiley +1 more source
ABSTRACT Objectives CAR‐T cell therapies such as lisocabtagene maraleucel (liso‐cel) have transformed the treatment of patients with second line primary refractory or early relapsed ≤ 12 months (R/R) large B‐cell lymphoma (LBCL). The objective of this study was to assess the cost‐effectiveness of liso‐cel compared to standard of care (SOC) to treat R/R
Catherine Thieblemont +6 more
wiley +1 more source
Rapidly Expanded EBV-Specific T Cells for the Treatment of Refractory EBV Reactivation and EBV-Related Lymphoproliferative Disorders. [PDF]
Schweitzer L +29 more
europepmc +1 more source
ABSTRACT Introduction The 2024 ISTH clinical practice guideline (CPG) for treatment of congenital haemophilia, the NBDF‐McMaster Guideline on Care Models for Haemophilia Management, and ASH ISTH NBDF WFH guidelines on the diagnosis and management of VWD all utilised GRADE methodology.
Mark W. Skinner +59 more
wiley +1 more source
Spontaneous Transdiaphragmatic Intercostal Hernia in an Elderly Patient: A Rare Case Treated by Laparoscopic Repair. [PDF]
Boukla J +4 more
europepmc +1 more source
The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease [PDF]
et al, +2 more
core +1 more source
This study assessed the 2022 WHO classification for predicting RAIR disease in thyroid carcinomas, comparing it to older classifications. In a retrospective study of 253 cases, we found the 2022 classification more effective, especially by identifying high‐grade carcinomas and tumour necrosis as critical predictive factors.
Elise André +10 more
wiley +1 more source

